Targeted Immunotherapy to Revolutionize Cancer Treatment with Carl June, MD -- Overthrowing the Emperor of all Maladies: Moving Forward Against Cancer Series -- Exploring Ethics
Date: 6/9/2014; 47 minutes

Copy the following code and paste it into your web page to embed this video:

Dr. Carl June presents a revolutionary form of targeted immunotherapy to fight cancer, a treatment that involves genetically modifying the patient's own T lymphocytes (a type of white blood cell) to attack cancer cells. Dr. June's team was the first to use these engineered T cells to treat Emily Whitehead, a six-year-old girl with acute leukemia, and now, two years later, she remains cancer-free. Similar results with other patients confirm that this type of T cell therapy is one of the most exciting new approaches to treating cancer, stimulating the biotechnology and pharma industries to develop the means to deliver this therapy to patients. Dr. June was presented by the Center for Ethics in Science and Technology in San Diego. Recorded on 05/14/2014. (#25970)

Sign up for UCTV's monthly e-newsletter:
contact info



where to watch

videos & podcasts

live stream


more info
about uctv


program contributors

university of california



©2016 Regents of the University of California. All right reserved. Terms and Conditions of Use.